MARKET

IDRA

IDRA

Idera Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.110
-0.040
-1.86%
Closed 16:00 11/15 EST
OPEN
2.150
PREV CLOSE
2.150
HIGH
2.170
LOW
2.060
VOLUME
100.32K
TURNOVER
--
52 WEEK HIGH
7.59
52 WEEK LOW
2.020
MARKET CAP
60.92M
P/E (TTM)
-1.3009
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of IDRA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

IDRA News

  • The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher
  • Benzinga.2d ago
  • Idera Pharmaceuticals EPS beats by $0.07
  • seekingalpha.11/07 02:58
  • Idera Pharmaceuticals Q3 EPS $(0.39) Beats $(0.46) Estimate
  • Benzinga.11/06 21:21
  • Idera Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2019 Financial Results
  • GlobeNewswire.11/06 21:01

More

Industry

Biotechnology & Medical Research
+1.49%
Pharmaceuticals & Medical Research
+1.29%

Hot Stocks

Name
Price
%Change

About IDRA

Idera Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapeutics for oncology and rare diseases. The Company utilizes two drug discovery technology platforms to design and develop drug candidates, which include Toll-like receptor (TLR) targeting technology and third-generation antisense (3GA) technology. Using TLR technology, the Company designs synthetic oligonucleotide-based drug candidates to act by modulating the activity of specific TLRs. Using its 3GA technology, the Company is developing drug candidates to turn off the messenger ribo nucleic acid (mRNA) associated with disease causing genes. The Company's drug candidates include IMO-8400, IMO-2125 and IMO-9200. The Company has designed TLR antagonists and agonists to act by modulating the activity of targeted TLRs. It is developing its 3GA technology to turn off the mRNA associated with disease causing genes.
More

Webull offers Idera Pharmaceuticals Inc (IDRA) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.